Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients

Completed

Conditions studied: Cachexia

In brief

The long-term objective of this research is to develop a non-invasive approach for early assessment of which patients are at high risk for future development of skeletal muscle atrophy. The investigators hypothesize that the rate constant for the terminal portion of the isotope decay curve following ingestion of a single oral dose of deuterated-3-methylhistidine (D-3MH) provides an accurate measure of this increased risk and that this rate constant can be measured non-invasively from timed spot urine samples.

Key facts

Study ID

NCT01015274

Run by

The University of Texas Medical Branch, Galveston

People needed

10

Starts

2009-10-01

Last updated by the study team

2018-07-11

Who can join

Age: 30 and older, up to 75. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male
• 30-75 years old
• Body Mass Index (BMI) <27 kg/m2

You may not qualify if…

• Uncontrolled hypertension
• Glomerular filtration rate less than 60 mL/min/1.73 m2
• History of recurrent gastrointestinal bleeding
• Unable or unwilling to provide informed consent
• Ongoing anti-coagulant therapy

Where it is running

• University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.